Skip to main content
Karo Pharma AB logo

Karo Pharma AB — Investor Relations & Filings

Ticker · KARO ISIN · SE0007464888 LEI · 213800G54Z51LOPGTA79 ST Manufacturing
Open in API
Filings indexed 653 across all filing types
Latest filing 2011-01-31 Share Issue/Capital Cha…
Country SE Sweden
Listing ST KARO

About Karo Pharma AB

https://www.karohealthcare.com/

Karo Pharma AB, operating as Karo Healthcare, is a healthcare company that develops, markets, and sells a broad portfolio of everyday healthcare products. The company's offerings are designed to prevent illness and treat common health problems, empowering consumers to manage their daily well-being. The portfolio consists of various branded medicines and consumer healthcare products distributed through pharmacies and directly to healthcare providers. With products available in over 90 countries, the company focuses on becoming a leading force in its sector by employing a consumer-centric approach, strategic innovation, and omnichannel excellence.

Recent filings

Filing Released Lang Actions
ÄNDRING AV ANTALET AKTIER OCH RÖSTER I KARO BIO AB (PUBL)
Share Issue/Capital Change Classification · 98% confidence The document is a press release (PRESSMEDDELANDE) dated January 31, 2011, announcing a change in the total number of shares and votes in Karo Bio AB. Specifically, it states the new total number of shares (387,063,972) resulting from a rights issue (förtresemission). This directly relates to changes in the company's capital structure and share count. This aligns perfectly with the definition for 'Share Issue/Capital Change' (Code: SHA). It is not a general earnings release (ER), an interim report (IR), or a director's dealing (DIRS). The document is short and serves as a direct notification of a capital event.
2011-01-31 Swedish
CHANGE IN NUMBER OF SHARES AND VOTES IN KARO BIO (PUBL)
Declaration of Voting Results & Voting Rights Announcements Classification · 99% confidence The document is a short press release announcing a specific change: the 'CHANGE IN NUMBER OF SHARES AND VOTES' following a rights issue. It explicitly states the new total number of shares (387,063,972) and attributes the increase to a previously announced rights issue. This directly relates to changes in the company's capital structure or share count. The most appropriate classification among the provided options is 'Share Issue/Capital Change' (SHA), as it details the final result of a capital raising/share issuance event.
2011-01-31 English
KARO BIO’S RIGHTS ISSUE FULLY SUBSCRIBED
Capital/Financing Update Classification · 98% confidence The document is a press release dated December 22, 2010, announcing that Karo Bio AB's rights issue of approximately SEK 325 million was fully subscribed. It details the subscription rates, allocation process for unsubscribed shares, expected trading dates for new shares, and the resulting changes in share capital and the number of shares. This content directly relates to a fundraising or capital structure change event. Based on the definitions, 'Capital/Financing Update' (CAP) is the most appropriate classification for an announcement detailing the successful completion and results of a rights issue.
2010-12-22 English
KARO BIOS FÖRETRÄDESEMISSION FULLTECKNAD
Share Issue/Capital Change Classification · 98% confidence The document is a press release dated December 22, 2010, announcing that Karo Bio AB's rights issue (företrädesemission) of approximately 325 million SEK was fully subscribed. It details the subscription rates, allocation principles for unsubscribed shares, expected listing dates for the new shares (BTA conversion), and the resulting increase in the number of shares and share capital. This content directly relates to a corporate financing activity, specifically the completion of a share issue/capital change. This aligns best with the 'Capital/Financing Update' category (CAP). Although it involves shares, it is the announcement of the *completion* of the financing event, not just a transaction in own shares (POS) or a general share issue announcement (SHA), but rather the outcome of a specific fundraising effort.
2010-12-22 Swedish
KARO BIO OFFENTLIGGÖR PROSPEKT GÄLLANDE FÖRETRÄDESEMISSIONEN
Capital/Financing Update Classification · 98% confidence The document is a press release dated November 25, 2010, titled "KARO BIO OFFENTLIGGÖR PROSPEKT GÄLLANDE FÖRETRÄDESEMISSIONEN" (Karo Bio publishes prospectus regarding the rights issue). It explicitly states that the prospectus regarding the rights issue has been approved and registered by the Swedish Financial Supervisory Authority (Finansinspektionen). The core subject is the announcement of a capital-raising activity (företrädesemission/rights issue) and the associated prospectus. This directly aligns with the definition of 'Capital/Financing Update' (CAP). Although it mentions the publication of a prospectus, the primary focus is the financing event itself, not just the announcement of the report's availability, making CAP a better fit than RPA or RNS, as it details the financing amount (approx. 325 million SEK).
2010-11-25 Swedish
KARO BIO ANNOUNCES PROSPECTUS FOR THE RIGHTS ISSUE
Capital/Financing Update Classification · 95% confidence The document is titled "KARO BIO ANNOUNCES PROSPECTUS FOR THE RIGHTS ISSUE" and explicitly states, "Karo Bio AB (publ) hereby announces the publication of the prospectus for the rights issue." It details the approval and registration of the prospectus by the Swedish Financial Supervisory Authority and outlines how shareholders will receive the document. This structure—announcing the availability/publication of a formal document (a prospectus related to a rights issue, which is a financing activity)—fits the definition of a Report Publication Announcement (RPA). While the underlying event is related to Capital/Financing (CAP), the document itself is the announcement of the publication of the financing document (prospectus), making RPA the most precise fit based on the provided definitions and the 'MENU VS MEAL' rule, as it is an announcement about a report/document release rather than the full prospectus itself. Given the context of a rights issue, it is closely related to financing, but RPA captures the nature of the communication.
2010-11-25 English

Browse filings by year

16 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.